CIK 0001604191 · Non-accelerated filer<br>Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464993860
- Phone
- 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Coelho Mary Theresa Director | Grant or award · Stock option (right to buy) | +34,482 | 34,482 | ||
| 2022-01-03 | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2022-01-03 | BORKOWSKI EDWARD Director | Grant or award · Stock option (right to buy) | +34,482 | 34,482 | ||
| 2022-01-03 | Pennington James CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +7,500 | 7,500 | ||
| 2022-01-03 | Oakes Gregory Director | Grant or award · Stock option (right to buy) | +34,482 | 34,482 | ||
| 2022-01-03 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Grant or award · Stock option (right to buy) | +10,000 | 10,000 | ||
| 2022-01-03 | Schramm Vern Lee Director | Grant or award · Stock option (right to buy) | +34,482 | 34,482 | ||
| 2021-09-09 | Coelho Mary Theresa Director | Grant or award · Stock option (right to buy) | +10,310 | 10,310 | ||
| 2021-07-09 | Pennington James CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2021-06-30 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Other disposition · Stock option (right to buy) | −35,006 | 0 | ||
| 2021-06-30 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Grant or award · Stock option (right to buy) | +35,006 | 35,006 | ||
| 2021-06-30 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Other disposition · Stock option (right to buy) | −250,000 | 0 | ||
| 2021-06-30 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2021-06-30 | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD | Other disposition · Stock options (right to buy) | −900,000 | 300,000 | ||
| 2021-06-30 | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD | Grant or award · Stock options (right to buy) | +900,000 | 900,000 | ||
| 2021-01-04 | Oakes Gregory Director | Grant or award · Options (right to buy) | +41,237 | 41,237 | ||
| 2021-01-04 | Schramm Vern Lee Director | Grant or award · Options (right to buy) | +41,237 | 41,237 | ||
| 2021-01-04 | Riddell Alastair Director | Grant or award · Options (right to buy) | +41,237 | 41,237 | ||
| 2021-01-04 | CASAMENTO CHARLES J Director | Grant or award · Options (right to buy) | +41,237 | 41,237 | ||
| 2021-01-04 | BORKOWSKI EDWARD Director | Grant or award · Options (right to buy) | +41,237 | 41,237 |
Page 4 of 7 · 136 trades